New AI tool aims to help doctors Fine-Tune diabetes treatment
NCT ID NCT07063420
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests a decision support system (software) that helps healthcare providers choose the best combination of diabetes drugs for people with type 2 diabetes who use insulin. The study will enroll 18 adults and compare blood sugar control using continuous glucose monitors with and without the software. The goal is to see if the tool improves glycemic outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Decision support system software
What this could lead to
If successful, this could help doctors better manage insulin and other diabetes medications, leading to improved blood sugar control for patients.
What could go wrong
This is a very small pilot study with only 18 participants, so results may not apply to everyone. The software is still experimental and may not improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES TREATED WITH INSULIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Virginia Center for Diabetes Technology
RECRUITINGCharlottesville, Virginia, 22903, United States
Contact
Contact
Contact
Contact Email: •••••@•••••